Resting Pulse: Effects & Evidence—what is proven and what isn’t

Resting Pulse (Resting Heart Rate) is often treated as a “health number” for the cardiovascular system. But: what you measure depends strongly on the context. So the question of whether you can lower your resting pulse with an intervention only makes sense when framed in terms of study endpoints (e.g., blood pressure, fitness, heart rate variability).

What “resting pulse” measures—and why results can vary

Direct Answer: Resting pulse is the resting heart rate (beats per minute) and is used as a marker for cardiovascular health. Whether it gets “better,” however, depends heavily on how and when you measure it and which factors are influencing you right now (sleep, stress, caffeine, prior activity).

In principle, resting pulse describes your heart rate in a state of relative rest. In practice, though, it is not always operationalized in the same way. In studies, conditions are often standardized (e.g., measurement after a rest period, same time of day, defined prior activity). In everyday life, that is much harder—an early-morning value after a poor night and a measurement after a relaxed evening are not physiologically comparable.

Common sources of variation:

• Time of day: Resting heart rate follows circadian patterns. The choice of time can mask or amplify trends.
• Prior activity: If you walked briefly beforehand, had a stressful workday, or even did intense training, resting pulse may “lag.”
• Stress and mood: Sympathetic activation raises heart rate; it can change quickly.
• Sleep quality: Poor sleep is associated in many populations with less favorable autonomic regulation—this can measurably affect resting pulse without necessarily meaning the heart is “fundamentally worse.”
• Caffeine/nicotine/alcohol: Caffeine can affect heart rate; nicotine can as well. This is not just an “acute” issue—timing can influence you across the day.

A key point for interpreting the evidence: Even if RCTs show effects on closely related endpoints (e.g., fitness, blood pressure), translating those findings into a change in resting pulse as a single value is not always directly 1:1. That’s why it can be more useful to treat changes over time as a trend (over days/weeks) and to prioritize measurement consistency (ideally same time of day and the same measurement routine).

If you think of “regulation” near resting pulse more as autonomic nervous system function, heart rate variability (HRV) comes into focus. This becomes especially clear when you examine interventions such as Tai Chi/Qigong with HRV-focused endpoints (see “Tai Chi and Qigong: Heart Rate Variability instead of resting pulse alone”).

Evidence hierarchy: what meta-analyses, RCTs, and observational data say

Direct Answer: Meta-analyses and RCTs are the best basis for estimating causal effects. But for “lowering resting pulse,” there aren’t always clean, direct RCT endpoints exactly on resting pulse. Instead, researchers often infer cardiovascular adaptation indirectly through blood pressure, fitness, or HRV. Observational data can show associations, but it cannot prove causation.

In the evidence hierarchy, meta-analyses from randomized controlled trials (RCTs) provide the strongest inferential power because they average results across multiple experiments, reducing random fluctuations. For the question of “lowering resting pulse,” though, the situation is nuanced: resting pulse is a common marker, but many studies are primarily designed around different endpoints.

What happens in practice:

• Directly for resting heart rate: There are RCTs and meta-analyses where resting heart rate is reported explicitly. One example is resistance training in type-2 diabetes, where the meta-analysis explicitly considers resting heart rate as an outcome (Lin et al., 2025, PMID 39956457).
• Indirectly via closely related endpoints: Many interventions target systems that are typically associated with resting heart rate, such as blood pressure or fitness. In hypertension, a dose-response meta-analysis in the context of aerobic training shows effects on blood pressure (Jabbarzadeh et al., 2024, PMID 37872373); whether and how strongly this translates into a measurable resting pulse effect is not guaranteed.
• Autonomic regulation rather than resting pulse: Heart rate variability (HRV) is a different, but related marker. Tai Chi/Qigong is evaluated in an HRV-oriented meta-analysis with moderators (baseline autonomy, intervention complexity) (Gunawan et al., 2026, PMID 41417690). This matters because “better autonomic balance” does not necessarily appear immediately as a resting pulse reduction.

Observational studies can show that people with higher resting pulse often have a higher risk of unfavorable cardiovascular trajectories. But that does not prove that an intervention lowers resting pulse causally—and thus improves risk—because association does not establish cause. That is exactly why, when it comes to causality, you should prioritize RCT/meta-analysis evidence.

Animal data are interesting for mechanisms, but they transfer only limitedly to “resting pulse in humans” because measurement conditions, human cardiac physiology, and lifestyle can vary widely. For everyday decision-making, rely on human studies.

Bottom line: If you choose measures that could influence resting pulse, the best approach is usually (1) to use interventions with robust effects on cardio-respiratory health (e.g., training, load management) and then (2) check whether, in your personal trend over time, resting pulse moves consistently.

Training as the first lever: why endurance and resistance training are most strongly supported

Direct Answer: For “improving resting pulse,” training overall is the best-supported lever. The data are especially strong when the study reports training and resting heart rate directly (e.g., resistance training in type-2 diabetes in Lin et al., 2025, PMID 39956457). In other populations, effects on closely related outcomes like blood pressure and fitness are well supported.

Why training is so plausible: Regular physical load changes cardiovascular function (e.g., efficiency of circulation, cardiovascular adaptations, and in part autonomic regulation). Even when the primary endpoint is not “resting pulse,” improvements in cardio-respiratory performance can still influence the resting state.

Type-2 diabetes: resistance training with resting heart rate as an outcome

The systematic review and meta-analysis on type-2 diabetes examines—among other things—the effect of resistance training on blood pressure and resting heart rate (Lin et al., 2025, PMID 39956457). Important caveat: this study isn’t just “plausible”; it treats resting pulse directly as a measured endpoint. If you target a population with a similar baseline situation to type-2 diabetes, this is a particularly relevant evidence layer.

Hypertension context: aerobic training via blood pressure effects

Even when evidence is driven primarily through blood pressure effects, it still matters because blood pressure and resting heart rate can often move together in day-to-day life and in pathophysiology. A dose-response meta-analysis on aerobic training and blood pressure in hypertension provides a strong foundation (Jabbarzadeh et al., 2024, PMID 37872373). This does not automatically imply a defined resting pulse reduction, but it supports the core assumption that structured movement influences the cardiovascular system in the intended target range.

Stroke patients: physiotherapy and cardiorespiratory fitness

For stroke patients, there is a systematic review and network meta-analysis on cardiorespiratory physiotherapy and cardiovascular fitness (Kim et al., 2025, PMID 41239708). Even if “resting pulse” is not necessarily the central outcome here, the evidence shows that structured training/physiotherapy programs can improve cardiovascular fitness. In many cases, this is a functional bridge to changes in resting heart rate, but methodologically it remains a more indirect inference unless resting pulse is reported as an outcome.

Practical takeaway

If your specific goal is “resting pulse,” two things matter most:

1. Structured training rather than isolated interventions.
2. Tracking as quality control, but not as a “decision authority” based on a single measurement point. Resting pulse fluctuates. Consistency over time is the key.

If you want to go further into which additional levers (besides training) influence the cardiovascular baseline, nutrition-related levers (e.g., carbohydrate periodization) can be useful—though they don’t replace training logic. See: Carbohydrate-Periodization: Effects & Evidence up to the Meta-Analysis.

Tai Chi and Qigong: heart rate variability instead of resting heart rate alone

Direct Answer: In the current evidence base, Tai Chi and Qigong are evaluated primarily via heart rate variability (HRV), not via a guaranteed resting pulse reduction. A meta-analysis shows effects on HRV and discusses moderators such as baseline autonomic function and intervention complexity (Gunawan et al., 2026, PMID 41417690). That can indirectly support improved resting regulation.

Why HRV is so central here: HRV and resting heart rate are not the same. HRV is often interpreted as a marker of autonomic nervous system regulation (especially vagal control). If an intervention improves autonomic regulation, that may—over the long term—contribute to more stable resting conditions. But: studies do not automatically report it as a “resting pulse reduction by X beats.”

What the meta-analysis addresses

Gunawan et al. examine Tai Chi and Qigong with a focus on HRV and explicitly assess:

• Baseline autonomic function (i.e., people with different starting states may respond differently),
• Intervention complexity (how “complex” the exercise is may correlate with the effect).

This is methodologically relevant: it helps explain why “just doing Tai Chi” does not work the same way for everyone. In people whose autonomic regulation is already well maintained, relative HRV changes could be smaller than in individuals with impaired baseline regulation.

What that means for resting pulse

If you want to lower resting pulse, the most honest translation of the evidence is:

• Realistic: Use HRV as a target value or as a proxy for “better regulation.”
• Resting pulse: treat it as a possible side effect, not as a primary, firmly established mechanism.

That does not mean resting pulse cannot move in a favorable direction. But the evidence in the cited meta-analysis provides primarily support for HRV endpoints (Gunawan et al., 2026, PMID 41417690). If your main goal is “resting pulse,” you might decide in parallel with HRV tracking: does HRV stay stable/improve? If yes, that is a plausible indicator that your autonomic regulation is truly benefiting.

Supplements vs lifestyle: Nitrates, Omega-3, and what that implies for resting pulse

Direct Answer: For resting heart rate, supplements are more “secondary” in the available study evidence compared with training, sleep, and movement. Chronic nitrates are studied in relation to blood pressure (Forster et al., 2026, PMID 41619653), and omega-3 in RCTs is evaluated mainly on the safety side in the context of bleeding risk (Javaid et al., 2024, PMID 38742535). That does not support a reliable resting pulse reduction.

Chronic nitrates: blood pressure is the endpoint

Forster et al. conduct a systematic review and meta-analysis on chronic nitrates and their effect on blood pressure (Forster et al., 2026, PMID 41619653). This is cardiovascularly relevant, but methodologically it is a different output than resting heart rate. So the evidence base is good for understanding blood pressure as a lever—not for guaranteeing a “resting pulse” change.

Important for interpretation:

• An effect on blood pressure may reduce load on the cardiovascular system.
• Whether and how strongly that shows up as a resting pulse change is not derived from the blood pressure evidence.

Omega-3 fatty acids: safety aspect rather than resting pulse effects

Javaid et al. evaluate bleeding risk in a systematic review and meta-analysis from randomized studies involving omega-3 polyunsaturated fatty acids (Javaid et al., 2024, PMID 38742535). This addresses a safety question, but it is not a study that places resting pulse as a signal of efficacy. For your goal of “lowering resting pulse,” it is therefore indirect and not primarily decisive.

Why lifestyle first still makes sense

The brand-critical methodological line is: if your goal is a physiological measure like resting pulse, you should first choose interventions that connect directly to cardiovascular adaptation in RCTs/meta-analyses—typically training and behavioral control (sleep quality, load management, endurance/resistance).

If you still consider supplements, the clean approach is:

• Separate the target clearly: “lowering blood pressure” ≠ “lowering resting pulse.”
• Check safety: especially if there could be interactions with medications. In your listed evidence, only the omega-3 safety aspect regarding bleeding risk is covered (see Javaid et al., 2024, PMID 38742535).
• Standardize measurement: treat resting pulse as a trend rather than a single result.

If you are also thinking about interactions (e.g., between supplements and medications, or methodological pitfalls when interpreting results), this context is relevant: Interactions: what studies support (and what they don’t).

Study overview: what fits directly to resting heart rate and what is more indirect

Additional context: cognition, vagal regulation, and populations with specific baseline conditions

Direct Answer: Resting pulse—and especially HRV—is strongly dependent on baseline physiological state and on factors that go beyond the cardiovascular system. Meta-analyses on vagally mediated HRV and the role of the autonomic nervous system support the concept that “rest regulation” does not respond the same way in everyone (Lim et al., 2026, PMID 41865891). For specific groups (e.g., PCOS), meta-data also suggest that baseline condition changes how you should interpret the relationship between HRV, resting pulse, and cardiovascular risk.

Vagally mediated regulation and HRV

Lim et al. report in a series of meta-analyses on perseverative cognition and vagally mediated heart rate variability in laboratory studies (Lim et al., 2026, PMID 41865891). This is relevant for the resting pulse topic because it supports the idea that “rest” is biologically regulated via the autonomic nervous system. If your mental/physiological baseline is different, an intervention may still affect the autonomic-regulatory system, but the change in resting pulse may be absent or appear delayed.

Polycystic ovary syndrome (PCOS): HRV as a population-specific issue

Mirzohreh et al. examine HRV in PCOS in a systematic review & meta-analysis and derive implications for cardiovascular health (Mirzohreh et al., 2024, PMID 39049099). Practical takeaway: In populations with specific hormonal and metabolic baselines, the relationship between HRV, resting heart rate, and cardiovascular risk can differ from what is seen in the general population. That makes a “resting pulse number for everyone” methodologically problematic.

What you can take from this

• Interventions are probabilistic: You can expect favorable effects on autonomic regulation or fitness, but resting pulse is not always the best single target parameter.
• Measurement interpretation depends on context: If you are in a risk group or have relevant symptoms, “resting pulse as a KPI” alone is not a medical decision.
• Think on outcome level: If a review evaluates HRV, that does not automatically mean it can be treated as the same as a resting pulse benchmark.

If you are unsure how to interpret resting pulse in a clinically relevant way (e.g., whether a change is meaningful), this is the area where medical guidance and parallel tracking of outcomes (e.g., blood pressure, fitness parameters, lab values depending on the situation) are especially important. The evidence you are using here mainly shows: the direction may be right, but translating it into “resting pulse reliably goes down” is not equally well supported across contexts.

What you take away from this

• Resting pulse is a marker, not “a single truth value”: time of day, sleep, stress, and caffeine make measurable fluctuations more likely.
• Training is the best starting point: in type-2 diabetes, a meta-analysis even looks directly at resting heart rate (Lin et al., 2025, PMID 39956457).
• Tai Chi/Qigong provides mainly HRV evidence: resting pulse is more likely a possible secondary effect because the meta-analysis uses HRV endpoints (Gunawan et al., 2026, PMID 41417690).
• Supplements are more secondary: nitrates are tested for blood pressure in the listed evidence (Forster et al., 2026, PMID 41619653), omega-3 primarily on safety (bleeding risk) (Javaid et al., 2024, PMID 38742535)—not a reliable direct resting pulse reduction.
• Context decides: HRV and resting regulation vary with baseline status and population (Lim et al., 2026, PMID 41865891; Mirzohreh et al., 2024, PMID 39049099).